Q-omics provides the consensus-scored MIR3928 profile across patient tissues and cancer cell-line models. MIR3928 expression is associated with patient survival in 15 of 34 cancer types, with the highest sampling consensus in HNSC. Among the 18 cancer types available for tumor–normal comparison, MIR3928 is differentially expressed in 5, with the highest sampling consensus in KIRC. Additionally, MIR3928 RNA expression shows 9,260 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight HNSC, KIRC, and THYM as cancer lineages where MIR3928 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR3928 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR3928 survival associations across molecular data types. MIR3928 RNA expression shows survival associations in the most cancer types (15). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR3928 RNA expression–survival associations across cancer types. High MIR3928 expression shows unfavorable associations in COAD, UCEC, STAD, UVM and THCA, but favorable associations in HNSC. The HNSC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify HNSC as the clearest survival context for MIR3928 RNA expression.
This table summarizes MIR3928 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 5. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for MIR3928. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR3928 shows lower tumor expression in PRAD and higher tumor expression in KIRC, KICH, UCEC and LUSC. The KIRC box plot shows higher MIR3928 RNA expression in tumor versus normal tissue (log2 FC = +0.267, t-test p = .005).
This table shows molecular features associated with MIR3928 in patient tissues and cancer cell lines. In patient samples, MIR3928 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
